Genenta Science S.p.A. (GNTA)

NASDAQ: GNTA · IEX Real-Time Price · USD

2.780

+0.110 (4.12%)

Apr 25, 2024, 10:54 AM EDT - Market open

Genenta Science Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-11.65	-8.48	-5.53	-5.59	-4.6
Depreciation & Amortization	0.04	0.01	0	0	0
Share-Based Compensation	0.74	0.72	0.5	0.46	0.75
Other Operating Activities	-0.34	0.33	-1.93	-0.91	1.36
Operating Cash Flow	-11.21	-7.42	-6.96	-6.04	-2.49
Capital Expenditures	-0.01	-0.03	-0.01	-0.02	0
Change in Investments	-14.88	0	0	0	0
Investing Cash Flow	-14.89	-0.03	-0.01	-0.02	0
Share Issuance / Repurchase	0	0	28.74	1.5	15.09
Other Financing Activities	-	-	-	-0.11	-0.32
Financing Cash Flow	0	0	28.74	1.39	14.77
Exchange Rate Effect	-0.01	0	0	0	0
Net Cash Flow	-26.1	-7.45	21.77	-4.68	12.28
Free Cash Flow	-11.22	-7.45	-6.97	-6.07	-2.49
Free Cash Flow Per Share	-0.62	-0.41	-0.46	-0.34	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).